GW Pharmaceuticals

0
45

Speculation is one of the more fun components of stock picking and investing. Finding companies that have an intriguing thesis, but might fail the specific criteria that we would typically require with other stocks in our portfolio. Speculation is exciting, speculating gives us the opportunity to find a stock that may give our portfolio a massive boost if we choose correctly. The cannabis industry has been one of the most speculative industries as of late, as investors reach for cannabis stocks in the hopes of a nationwide legalization.

The Trump administration seems to be pumping the brakes on nationwide legalization at the moment. This crackdown has hurt cannabis stocks in the short term, but with a black market worth more than $45 billion in the United States alone, there has to be some potential here right? I mean, Colorado’s legal cannabis market is currently topping $1 billion in total revenue alone.

One of the problems that I have with most of the speculative cannabis stocks is that most are far too speculative to own. Aurora Cannabis (OTC: OTCQX:ACBFF), Cara Therapeutics (NASDAQ:CARA), INSYS Therapeutics (NASDAQ:INSY), Mass Roots (OTC: OTCQB:MSRT) to name a few, are all far too speculative for my preference. However, there is one option I would consider in the cannabis industry.

To continue reading CLICK HERE!

LEAVE A REPLY

Please enter your comment!
Please enter your name here